Clinical trial
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 · Vernalis (R&D) Ltd, Industry · Completed
Key facts
| NCT number | NCT00144014 |
|---|---|
| Title | Safety and Efficacy Study in Acute Ischaemic Stroke |
| Official title | A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke. |
| Acronym | VASST |
| Lead sponsor | Vernalis (R&D) Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | V10153 |
| Enrollment | 49 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Jun 3, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: